Higher IOP may be marker for CVD

Article

Higher IOP may be a predictable marker of cardiovascular disease (CVD) in some individuals, according to a study from South Korea.

Higher IOP may be a predictable marker of cardiovascular disease (CVD) in some individuals, according to a study from South Korea published in the British Journal of Ophthalmology. The researchers found that higher IOP is associated with the presence of coronary artery calcium (CAC) in asymptomatic patients, regardless of the presence of usual cardiovascular risk factors.

The researchers’ cross-sectional study included 10,732 men and women without diagnoses of CVD or glaucoma. They measured CAC using cardiac computed tomography and IOP using a non-contact tonometer and automatic air puff control.

The researchers detected CAC in 13.7% in men and 4.3% of women. They found that increasing levels of right IOP were significantly associated with an increased prevalence of CAC. They adjusted for multiple factors - age, sex, tobacco use, alcohol use, physical activity, body mass index, educational level, centre, family history of CVD, use of dyslipidemia medication, diabetes, hypertension, total cholesterol level, high-density lipoprotein cholesterol and triglycerides - and found that the odds ratios for CAC score >0, comparing 2–4 quartiles of the right IOP with the lowest quartiles, were 1.32, 1.20 and 1.28, respectively. The associations were the same among the clinically relevant subgroups.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.